Sungkyunkwan University, KIST researchers develop innovative anticancer platform
A Sungkyunkwan University research team has developed an innovative cancer treatment platform in collaboration with researchers at the Korea Institute of Science and Technology (KIST). Sungkyunkwan University said the platform is designed to simultaneously identify cancer cells and the surrounding cells that support them and block communication between the two at its source by suppressing the…
Sungkyunkwan University researchers, in partnership with the Korea Institute of Science and Technology (KIST), have created a groundbreaking anticancer platform. This innovative technology aims to pinpoint cancer cells and the surrounding support cells, then inhibit their communication by reducing the production of extracellular vesicles.
Professor Yang Yoo-soo, from Sungkyunkwan University's integrative biotechnology department, led the research team. The project was a collaborative effort with Dr. Shim Man-kyu's KIST team. Cancer cells do not proliferate independently; they are surrounded by cancer-associated fibroblasts and various immune cells, forming a complex community known as the tumor microenvironment.
These cells communicate via tiny packages called extracellular vesicles, which contain signaling molecules. By disrupting this exchange, the new platform aims to limit cancer cells' growth and prevent their spread to other organs.
Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
